Zobrazeno 1 - 10
of 104
pro vyhledávání: ''
Autor:
Kaito Shibata, Junichi Kawakami, Satoshi Hirakawa, Hiroyuki Mineta, Seiji Hosokawa, Koji Suzuki, Takafumi Naito
Publikováno v:
Cancer Chemotherapy and Pharmacology. 87(4):555-565
Purpose: Cetuximab inhibits epidermal growth factor receptor (EGFR) signaling in cancer and skin cells, thereby inducing anti-cancer effects and skin disorders. The present study aimed to evaluate the relationships between serum cetuximab and EGFR-re
Autor:
Yiping Chen, Iona Y Millwood, Zheng Bian, Yuanjie Pang, Christiana Kartsonaki, Michael V. Holmes, Jun Lv, Zhengming Chen, Canqing Yu, Ling Yang, Ju Zou, Yu Guo, Junshi Chen, Xiaojun Li, Robin G. Walters, Liming Li
Publikováno v:
Br J Cancer
Background: Gallstone disease (GSD) is associated with a higher risk of gastrointestinal (GI) cancer. However, it is unclear whether the associations are causal. Methods: The prospective China Kadoorie Biobank (CKB) recorded 17,598 cases of GI cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c748012aa0284d19fe54bbbd37ba9294
https://ora.ox.ac.uk/objects/uuid:60aa7e21-9bb4-4be7-991e-55c03ad9e1e0
https://ora.ox.ac.uk/objects/uuid:60aa7e21-9bb4-4be7-991e-55c03ad9e1e0
Autor:
Michele Cavo, Richard Labotka, Philippe Moreau, S. Vincent Rajkumar, Meletios A. Dimopoulos, Wee Joo Chng, Gabor Mikala, Karthik Ramasamy, Hartmut Goldschmidt, Maria-Victoria Mateos, Zhaoyang Teng, Katja Weisel, Kaveri Suryanarayan
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
Leukemia
instname
Leukemia
In the TOURMALINE-MM3 study, post-autologous stem cell transplantation maintenance therapy with the oral proteasome inhibitor ixazomib versus placebo significantly improved progression-free survival (PFS), with a favorable safety profile. With ixazom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14b17e817155b269426fb09959074ffb
http://hdl.handle.net/10261/222773
http://hdl.handle.net/10261/222773
Autor:
Udo Bavendiek, Robert Geffers, Maximilian Brandes, Timon Seeger, Arnold Ganser, Michael Heuser, Joerg Heineke, David John, Brigitte Schlegelberger, Piroska Klement, Razif Gabdoulline, Abel Martin Garrido, Felicitas Thol, Johann Bauersachs, Gudrun Göhring, Amir Shirvani, Badder Kattih, Anuhar Chaturvedi, Alessandro Liebich
Publikováno v:
Leukemia
Clonal hematopoiesis of indeterminate potential (CHIP) is linked to leukemia gene mutations and associates with an increased risk for coronary artery disease and poor prognosis in ischemic cardiomyopathy. Two recurrently mutated genes in CHIP and adu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2024100c560082a18b7bc28f0645166
https://hdl.handle.net/10033/622512
https://hdl.handle.net/10033/622512
Autor:
Shunsuke Kaji, Ryoji Hyakudomi, Takahito Taniura, Yoshitsugu Tajima, Yusuke Fujii, Noriyuki Hirahara, Tetsu Yamamoto, Yasunari Kawabata
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-11 (2018)
BMC Cancer
BMC Cancer
Background An ideal tumor marker should be capable of being detected at any stage of the disease. However, gastric cancer patients do not always have elevated serum carcinoembryonic antigen (CEA) levels, even in advanced cases. Recently, several stud
Autor:
M. Dzugashvili, P. Castañeda, J.L. López-Guerra, J. M. Díaz, Juan Manuel Praena-Fernández, A. Fondevilla Soler, E. Rivin del Campo, A. Sautbaet, P. Sempere Rincón, Ignacio Azinovic
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
[Purpose] The aim of this study was to assess the feasibility and treatment outcome of intensity modulated radiation therapy with simultaneous integrated boost (SIB-IMRT) in locally advanced non-small cell lung cancer (NSCLC) patients.
[Material
[Material
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddde6cfed912baefc7fcbdb7e9cbf802
http://hdl.handle.net/10261/198672
http://hdl.handle.net/10261/198672
Autor:
Francesca Bergamo, Chiara Briani, Sara Lonardi, Guido Cavaletti, Paola Alberti, Marina Cazzaniga, Jordi Bruna, Andreas A. Argyriou, Diego Cortinovis, Marta Lucchetta, Haralabos P. Kalofonos, Roser Velasco
Context Peripheral, acute or chronic, neurotoxicity is one of the main dose-limiting adverse effects of oxaliplatin (OXA). Acute neurotoxicity is typically characterized by distal and perioral cold-induced paresthesias and dysesthesias, but other unc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::133e3fe98804dec729026198c01562f4
http://hdl.handle.net/10281/44806
http://hdl.handle.net/10281/44806
Autor:
Nilgun F Hatabay, Mehmet Aliustaoglu, Taflan Salepci, Orhan Türken, A. Ozkan, Rengin Ahiskali, Perran Fulden Yumuk, Nazim Serdar Turhal, Mahmut Gumus
Publikováno v:
BMC Cancer
BMC Cancer, Vol 5, Iss 1, p 10 (2005)
BMC Cancer, Vol 5, Iss 1, p 10 (2005)
Background Both paclitaxel (P) and carboplatin (C) have significant activity in non-small cell lung cancer (NSCLC). The weekly administration of P is active, dose intense, and has a favorable toxicity profile. We retrospectively reviewed the data of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32ed3301165196a0a4507d14e036335d
https://hdl.handle.net/20.500.12415/7897
https://hdl.handle.net/20.500.12415/7897
Autor:
Peter Gedeon, Håkan Griph, Ana Carneiro, Viktoria Bergqvist, Marija Kopljar, Sara Kinhult, Erik Hertervig, Jan Marsal
Publikováno v:
Cancer Immunology, Immunotherapy
Immune checkpoint inhibitors (ICPI), such as ipilimumab [anti-cytotoxic T-lymphocyte antigen-4 (CTLA-4) antibody] and nivolumab or pembrolizumab [anti-programmed cell death protein-1 (PD-1) antibodies], improve survival in several cancer types. Since
Publikováno v:
Medical Oncology (Northwood, London, England)
Thromboembolic events (TEE) are a serious clinical problem in multiple myeloma (MM) patients receiving thalidomide (T). Thirty-one MM patients were tested on diagnosis and after 2 and 4 weeks of therapy with T alone, or T in combination with dexameth